SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001493152-21-007476
Filing Date
2021-03-31
Accepted
2021-03-31 16:33:42
Documents
87
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-kt.htm 10-KT 1676154
2 ex4-3.htm EX-4.3 49722
3 ex4-13.htm EX-4.13 56211
4 ex4-14.htm EX-4.14 45817
5 ex10-31.htm EX-10.31 18483
6 ex21-1.htm EX-21.1 1775
7 ex23-1.htm EX-23.1 3092
8 ex31-1.htm EX-31.1 10851
9 ex31-2.htm EX-31.2 10986
10 ex32-1.htm EX-32.1 8681
  Complete submission text file 0001493152-21-007476.txt   6765690

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE qlgn-20201231.xml EX-101.INS 1032386
12 XBRL SCHEMA FILE qlgn-20201231.xsd EX-101.SCH 74455
13 XBRL CALCULATION FILE qlgn-20201231_cal.xml EX-101.CAL 86408
14 XBRL DEFINITION FILE qlgn-20201231_def.xml EX-101.DEF 310907
15 XBRL LABEL FILE qlgn-20201231_lab.xml EX-101.LAB 513459
16 XBRL PRESENTATION FILE qlgn-20201231_pre.xml EX-101.PRE 409299
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-KT | Act: 34 | File No.: 001-37428 | Film No.: 21793908
SIC: 2834 Pharmaceutical Preparations